ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,518,000 | +71.0% | 583,428 | +2.1% | 0.01% | +60.0% |
| Q3 2019 | $2,057,000 | +98.9% | 571,428 | +48.1% | 0.01% | +66.7% |
| Q2 2019 | $1,034,000 | +17.0% | 385,828 | +29.2% | 0.00% | +50.0% |
| Q1 2019 | $884,000 | +80.8% | 298,728 | -3.0% | 0.00% | +100.0% |
| Q4 2018 | $489,000 | +840.4% | 307,828 | +2096.7% | 0.00% | – |
| Q3 2018 | $52,000 | -46.4% | 14,013 | -59.3% | 0.00% | – |
| Q2 2018 | $97,000 | -69.1% | 34,413 | -68.4% | 0.00% | -100.0% |
| Q4 2017 | $314,000 | +30.8% | 108,913 | +87.2% | 0.00% | 0.0% |
| Q4 2016 | $240,000 | -7.0% | 58,185 | +82.8% | 0.00% | 0.0% |
| Q3 2016 | $258,000 | +40.2% | 31,828 | +34.7% | 0.00% | 0.0% |
| Q2 2016 | $184,000 | -36.3% | 23,628 | -36.8% | 0.00% | -50.0% |
| Q1 2016 | $289,000 | -53.0% | 37,400 | -34.4% | 0.00% | -50.0% |
| Q4 2015 | $615,000 | -34.4% | 57,000 | -39.4% | 0.00% | -42.9% |
| Q3 2014 | $938,000 | +70.9% | 94,028 | +29.7% | 0.01% | +75.0% |
| Q2 2014 | $549,000 | – | 72,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,733,815 | $81,081,000 | 11.64% |
| RTW INVESTMENTS, LP | 2,589,818 | $17,896,000 | 5.56% |
| DAFNA Capital Management LLC | 480,300 | $3,319,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 510,125 | $3,525,000 | 1.83% |
| Sio Capital Management, LLC | 364,368 | $2,518,000 | 1.73% |
| TURNER INVESTMENTS LLC | 1,086,000 | $7,504,000 | 1.52% |
| Ghost Tree Capital, LLC | 300,000 | $2,073,000 | 0.93% |
| Rock Springs Capital Management LP | 1,125,000 | $7,774,000 | 0.63% |
| SENZAR ASSET MANAGEMENT, LLC | 619,000 | $4,277,290,000 | 0.62% |
| Point72 Asset Management, L.P. | 9,772,018 | $67,525,000 | 0.53% |